Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 5, 1999, Pages 443-446

  Cheng, Danny ^a   Chan, Yik Ming ^a   Ng, Tong Yow ^a   Cheung, Annie N Y ^a   Ngan, Hextan Y S ^a   Wong, Ling Chui ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gynecological malignancy; Mitomycin; Palliation; Pleurodesis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; OVARY CANCER; PLEURA EFFUSION; PLEURODESIS; PNEUMOTHORAX; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; THORACOCENTESIS; THORAX DRAINAGE; UTERINE CERVIX CANCER;

EID: 0032942626     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1999.780518.x     Document Type: Article

References (15)

1. 1. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987; 31: 85-97.
2. 2. Ruckdeschel JC, Moores D, Lee JY et al. Intrapleural therapy for malignant pleural effusion. Chest 1991; 100: 1528-35.
3. 3. Sanchez-Armengol A, Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993; 104: 1482-5.
4. 4. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Cancer 1995; 108: 289-90.
5. 5. Goff BA, Mueller PR, Muntz HG, Rice LW. Small chesttube drainage followed by bleomycin sclerosis for malignant pleural effusions. Obstet Gynecol 1993; 81: 993-6.
6. 6. Hausheer FH, Yabro JW. Diagnosis and treatment of malignant pleural effusion. Semin Oncol 1985; 12: 54-75.
7. 7. Leff A, Hopewell PC. Pleural effusion from malignancy. Ann Int Med 1978; 88: 523-37.
8. 8. Dvoretsky PM, Richards KA, Bonfiglio TA. The pathology and behavior of ovarian cancer. Path Ann 1989; 24: 1-24.
9. 9. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusion. Cancer 1974; 33: 916-22.
10. 10. Fentiman IS, Rubens RD, Hayward JL. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Clin Oncol 1986; 22: 1079-81.
11. 11. Milanez RC, Vargas FS, Filomeno LB et al. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer. Cancer 1995; 75: 2688-92.
12. 12. Audu PB, Sing RF, Fallahnejhad M. Fatal diffuse alveolar injury following use of intrapleural Bleomycin [Letter]. Chest 1993;103:1638.
13. 13. Luh KT, Yang PC, Kuo SH, Chang DB, Yu CY, Lee LN. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusions caused by lung cancer. Cancer 1992; 69: 674-9.
14. 14. Saute M. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting. Isr J Med Sci 1995; 31: 160-2.
15. 15. Villanueva AG, Gray JW, Jr., Shahian DM, Williamson WA, Beamis JF, Jr. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49: 23-5.